Pharmacology and Toxicology Faculty
The following is a list of full and associate faculty with whom students may pursue their research. Students wishing to conduct research with associate faculty members are required to obtain permission from the Executive Council.
CORE FACULTY
Todd Camenisch, assistant professor, PhD, Pharmacology & Toxicology
Investigating the integration between extracellular matrix and growth factor receptor signaling during heart morphogenesis.
Qin Chen, associate professor, PhD, Pharmacology
Molecular mechanisms of oxidative injury and adaptation, stress signal transduction pathways, stress gene expression, senescence, apoptosis and cardiac hypertrophy.
Nathan Cherrington, assistant professor, PhD, Pharmacology & Toxicology
Studying molecular mechanisms of hepatotoxicity during cholestasis and employing a functional genomics approach based on flexible small-scale arrays to measure the expression of xenobiotic transporter and drug metabolism genes.
Bernard W. Futscher, associate professor, PhD, Pharmacology and Toxicology
Functional genomics; molecular biology of cancer; cancer pharmacology.
A. Jay Gandolfi, professor; PhD, Pharmacology and Toxicology
Bioactivation of xenobiotics: in vitro toxicology systems; renal/hepatic toxicology; toxicity of halogenated hydrocarbons, and metals; mechanisms cell injury.
Walter Klimecki, assistant professor, PhD, Pharmacology and Toxicology
My laboratory studies how the genes that people inherit from their ancestors set the stage for unique interactions with the environments that those people are exposed to throughout their life, to increase or decrease their susceptibility to disease. Those environmental exposures could be diverse, ranging from environmental toxicant chemicals to airborne bacterial contaminants to prescribed drugs. The combination of humans' diverse genetic backgrounds and equally diverse environmental exposures present both challenges and opportunities to understand individual variability in disease susceptibility.
Serrine Lau, professor, PhD
Genomic and proteomic approaches to investigate ROS and chemical-induced cell injury and carcinogenicity; molecular mechanisms of prostanoid mediated cytoprotection; mass spectrometric application of protein profiling and tissue imaging.
R. Clark Lantz, associate professor, PhD, Cell Biology and Anatomy
Pulmonary toxicology of air pollutants, especially metals; effects of air pollutants on neonatal lung growth and development
Terrence J. Monks, professor & head, PhD, Pharmacology and Toxicology
Molecular mechanisms of chemical-induced toxicities; stress response pathways and apoptotic/oncotic cell death; ROS-induced DNA damage and chromatin structure/function.
John W. Regan, professor, PhD, Pharmacology and Toxicology
Molecular pharmacology of G-protein coupled receptors: use of cloning, mutagenesis and expression to study receptor structure and the interaction of receptors with second messenger systems.
Catharine L. Smith, associate professor, PhD, Pharmacology and Toxicology Epigenetic mechanisms of gene regulation, steroid receptor action in breast cancer, signal transduction and cell cycle control, mechanism of anti-cancer drug action.
Richard R. Vaillancourt, associate professor, PhD, Pharmacology and Toxicology
Molecular and biochemical characterization of serine/threonine protein kinases that function as part of sequential protein kinase pathways.
Donna Zhang, assistant professor, PhD, Pharmacology and Toxicology
The Nrf2/Keap1 signaling pathway that is activated by oxidative stress and chemopreventive compounds; Regulation of gene expression by the ubiquitination and proteasomal degradation pathway
ASSOCIATE FACULTY
G. Timothy Bowden, professor, PhD, Radiation Oncology
Molecular aspects of chemical and physical carcinogenesis, mechanisms of oncogene activation and tumor suppressor gene inactivation.
Chris Hulme, D. Phil, Oxon., Associate Professor
Discovery and development of novel anticancer therapeutics; high-throughput medicinal chemistry and the development of novel chemistries with iterative efficiency to expedite the drug discovery process; Microwave Assisted Organic Synthesis (MAOS), Flow chemistry, Multicomponent reactions (MCRs) and C-H bond activation methodologies utilizing hypervalent iodine reagents for the design of peptidomimetics.
Patricia Hoyer, Appointed Personnel, Physiology, Adjunct Professor Pharmacology and Toxicology
Female reproduction: mechanisms of hormone action; regulation of steroidogenesis
Laurence H. Hurley, professor; PhD, Pharmacology and Toxicology
Discovery and development of novel anticancer drugs; telomeres; telomerase; transcriptional control; topoisomerases as drug targets. Targeting transcriptional control; c-MYC, VEGF, Bcl-2; secondary DNA structures; biophysical methods; molecular biology.
Elaine L. Jacobson, professor, PhD, Pharmacology and Toxicology
Optimizing molecular and cellular responses to UV radiation in skin; inhibition of advanced glycation end-products; DNA damage and repair.
Myron K. Jacobson, professor, PhD, Pharmacology and Toxicology
Molecular Mechanisms Involved in Maintenance of Genomic Integrity.
George Wondrak assistant professor, PhD, Pharmacology and Toxicology
Molecular pathways of skin photocarcinogenesis
that involve cellular photooxidative and carbonyl stress; Developing chemical reagents into potent drugs that target reactive chemical intermediates
Danzhou Yang, Ph.D, University of Illinois, assistant professor
Interaction of Camptothecin Anticancer Drugs with DNA and Topoisomerase I
Further information
For general questions regarding the graduate programs in the College of Pharmacy, contact Nancy Colbert, program coordinator, (520) 626-7265 or by fax (520)626-2466